March 18, 2026 12:20 AM PDT
This strategy creates a more "immunogenic" tumor cell line that can effectively mimic the natural interaction between IL-15 and its receptors. Research indicates that engineering cancer cells with IL-15 significantly boosts the persistence of memory T cells, leading to more sustained and potent therapeutic outcomes in various cancer models.
This strategy creates a more "immunogenic" tumor cell line that can effectively mimic the natural interaction between IL-15 and its receptors. Research indicates that engineering cancer cells with IL-15 significantly boosts the persistence of memory T cells, leading to more sustained and potent therapeutic outcomes in various cancer models.